Concord Biotech jumps 8% on USFDA nod for Mycophenolate Mofetil oral suspension

June 3, 2026

Concord Biotech shares saw a significant jump on Wednesday. This surge followed the company’s announcement of receiving approval from the USFDA for its Mycophenolate Mofetil for Oral Suspension. This antimetabolite immunosuppressant is used in organ transplant patients.

More To Explore

Pristine Logistics confidentially files IPO docs with Sebi

Pristine Logistics and Infraprojects has confidentially filed its DRHP with Sebi for an IPO. The rail-focused multimodal logistics company is expanding terminals, warehousing and cargo

June 29, 2026

Eswari Global Metal files papers for Rs 1,100-1,300-cr IPO

Eswari Global Metal Industries is poised for a major Initial Public Offering (IPO) with an ambitious target of raising Rs 1,100 to Rs 1,300 crore.

June 29, 2026

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. This website and its content are not intended for residents of the UAE, US, Canada, Australia, UK, Russia, North Korea, China, Japan, Hong Kong, Singapore and Iran.

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003